Pierre W Wijermans - JoVE Visualize

Showing results (41-50 of 42) with videos related to

Pageof 5

Sort By:

You have reached the last page of results.This site can display upto 42 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012

Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trialPieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, et al.

The Lancet. Haematology|November 1, 2023

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trialMichael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.

Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:

Pageof 5

You have reached the last page of results.This site can display upto 42 results.

Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 18, 2012

Bortezomib induction and maintenance treatment in patients with newly diagnosed multiple myeloma: results of the randomized phase III HOVON-65/ GMMG-HD4 trialPieter Sonneveld, Ingo G H Schmidt-Wolf, Bronno van der Holt, et al.

The Lancet. Haematology|November 1, 2023

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia: an open-label, randomised, controlled, phase 3 trialMichael Lübbert, Pierre W Wijermans, Michal Kicinski, et al.

Pageof 5